Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer
SF Shariat, MJ Marberger, Y Lotan… - The Journal of …, 2006 - Elsevier
PURPOSE: We assessed variability in the diagnostic performance of NMP22® for detecting
recurrence and progression in patients with Ta, T1, and/or CIS transitional cell carcinoma of
the bladder in a large international cohort. MATERIALS AND METHODS: NMP22® voided
urine levels were measured in 2,871 patients who underwent office cystoscopy for
monitoring previous stage Ta, T1 and/or CIS transitional cell carcinoma at 12 participating
institutions. RESULTS: Patient characteristics varied considerably among institutions …
recurrence and progression in patients with Ta, T1, and/or CIS transitional cell carcinoma of
the bladder in a large international cohort. MATERIALS AND METHODS: NMP22® voided
urine levels were measured in 2,871 patients who underwent office cystoscopy for
monitoring previous stage Ta, T1 and/or CIS transitional cell carcinoma at 12 participating
institutions. RESULTS: Patient characteristics varied considerably among institutions …
以上显示的是最相近的搜索结果。 查看全部搜索结果